Question: considering 21 CFR 56.111, what additional measures IRB should consider so that people participating in clinical trials has included details of their previous side affects

considering 21 CFR 56.111, what additional measures IRB should consider so that people participating in clinical trials has included details of their previous side affects and are not affected in future ?

Step by Step Solution

There are 3 Steps involved in it

1 Expert Approved Answer
Step: 1 Unlock blur-text-image
Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock
Step: 3 Unlock

Students Have Also Explored These Related General Management Questions!